First clinical results of a personalized immunotherapeutic vaccine against recurrent, incompletely resected, treatment-resistant glioblastoma multiforme (GBM) tumors, based on combined allo- and auto-immune tumor reactivity

Autor: Schijns, Virgil E.J.C., Pretto, Chrystel, Devillers, Laurent, Pierre, Denis, Hofman, Florence M., Chen, Thomas C., Mespouille, Pascal, Hantos, Peter, Glorieux, Philippe, Bota, Daniela A., Stathopoulos, Apostolos

Publikováno v: In Vaccine 28 May 2015 33(23):2690-2696

Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation.

Autor: Stathopoulos, Apostolis^1,2, Pretto, Chrystel², Devillers, Laurent², Pierre, Denis², Hofman, Florence M.^2,3, Kruse, Carol⁴, Jadus, Martin R.^5,6, Chen, Thomas C.^2,7, Schijns, Virgil E.J. C.^2,8

Publikováno v: OncoImmunology. May/Jun2012, Vol. 1 Issue 3, p298-305. 8p.

ATIM-20. A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED PHASE 2 STUDY OF THE ERC-1671 (GLIOVAC) VACCINE IN COMBINATION WITH BEVACIZUMAB (BEV) IN RECURRENT GBM PATIENTS: SAFETY LEAD-IN ANALYSIS

Autor: Bota, Daniela, Carrillo, Jose, Kong, Xiao-Tang, Fu, Dan, Chung, Jinah, Pretto, Chrystel, Strik, Ankie, Schijns, Virgil, Stathopoulos, Apostolos

Publikováno v: Neuro-Oncology, vol 18, iss suppl_6

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::c431ed2fae6534e000311cc937c67561
https://escholarship.org/uc/item/7g0141qz

FIRST REPORT OF ERC-1671 (GLIOVAC) VACCINE USE IN GLIOBLASTOMA PATIENTS WITH RECURRENT DISEASE

Autor: Bota, Daniela A, Pretto, Chrystel, Hantos, Peter, Hofman, Florence M, Chen, Thomas C, Carrillo, Jose A, Schijns, Virgil E, Stathopoulos, Apostolos Apostolos

Publikováno v: Bota, Daniela A; Pretto, Chrystel; Hantos, Peter; Hofman, Florence M; Chen, Thomas C; Carrillo, Jose A; et al.(2012). FIRST REPORT OF ERC-1671 (GLIOVAC) VACCINE USE IN GLIOBLASTOMA PATIENTS WITH RECURRENT DISEASE. NEURO-ONCOLOGY, 14, 48-48. UC Office of the President: Research Grants Program Office (RGPO). Retrieved from: http://www.escholarship.org/uc/item/4rj898p7

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::130f32189817bf9855ec9721a14690b9
http://www.escholarship.org/uc/item/4rj898p7

Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report.

Autor: Bota, Daniela A., Alexandru-Abrams, Daniela, Pretto, Chrystel, Hofman, Florence M., Chen, Thomas C., Fu, Beverly, Carrillo, Jose A., Schijns, Virgil E. J. C., Stathopoulos, Apostolos

Publikováno v: Permanente Journal; Spring2015, Vol. 19 Issue 2, p41-46, 6p